Loading company…
T Cell Tech develops immunotherapy treatments and other therapeutic products.
T Cell Tech is a biotechnology company developing therapies in immunotherapy. Founded in 2017, it is based in Fuzhou, China. In July 2025, it raised USD 40.00 mn in Series B funding led by SDIC Fund Management, with Lotus Lake Capital and Industrial Guoxin Asset Management Co., Ltd. participating. The funding will support clinical development of TX-103 in China and the United States.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in